Track COSMOS Pharmaceutical's inventory ($99B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
COSMOS Pharmaceutical posts a inventory of $99B as of May 2026. That compares with $92B in the prior-year period — up 7.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, COSMOS Pharmaceutical's inventory was $92B. The latest reading is $99B — a 7.3% year-over-year increase (period ending May 2026). Use the history and growth charts on this page for a longer lookback.
Inventory is one piece of COSMOS Pharmaceutical's financial statement story. At $99B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for CSMYF's inventory usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; COSMOS Pharmaceutical's other metric pages and overview cover the third.